Waddill William D. Insider Trading -- Recent SEC Form 4 Transactions

Waddill William D. (CIK 1553338) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-25). Recent activity: Buy PTGX (9,000 shares), Sell PTGX (9,000 shares), Buy PTGX (3,000 shares), Buy PTGX (6,000 shares), Sell PTGX (9,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-25Protagonist Therapeutics, Inc (PTGX)DirectorBuy9,000$148,860
2026-06-25Protagonist Therapeutics, Inc (PTGX)DirectorSell9,000$1.1M
2026-06-11Protagonist Therapeutics, Inc (PTGX)DirectorBuy3,000$35,400
2026-06-11Protagonist Therapeutics, Inc (PTGX)DirectorBuy6,000$99,240
2026-06-11Protagonist Therapeutics, Inc (PTGX)DirectorSell9,000$969,120
2026-06-01Protagonist Therapeutics, Inc (PTGX)DirectorBuy9,000$106,200
2026-06-01Protagonist Therapeutics, Inc (PTGX)DirectorSell9,000$896,760
2026-02-06Protagonist Therapeutics, Inc (PTGX)DirectorBuy20,000$166,200
2026-02-06Protagonist Therapeutics, Inc (PTGX)DirectorSell20,000$1.7M
2026-01-06Protagonist Therapeutics, Inc (PTGX)DirectorBuy2,695$0
2025-12-23ARROWHEAD PHARMACEUTICALS, INC. (ARWR)DirectorSell2,416$161,051
2025-12-23ARROWHEAD PHARMACEUTICALS, INC. (ARWR)DirectorSell5,451$370,723
2025-12-23ARROWHEAD PHARMACEUTICALS, INC. (ARWR)DirectorSell500$34,265
2025-12-18ARROWHEAD PHARMACEUTICALS, INC. (ARWR)DirectorBuy7,819$0
2025-10-14Protagonist Therapeutics, Inc (PTGX)DirectorBuy12,000$83,760
2025-10-14Protagonist Therapeutics, Inc (PTGX)DirectorSell4,000$277,000
2025-10-14Protagonist Therapeutics, Inc (PTGX)DirectorSell8,000$702,480
2025-09-24Protagonist Therapeutics, Inc (PTGX)DirectorSell4,000$257,000
2025-08-29Protagonist Therapeutics, Inc (PTGX)DirectorSell4,000$237,000

Source: SEC Form 4 filings · as of 2026-06-25